4D Molecular Therapeutics (FDMT) Q3 2024 Earnings

8AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.74
-0.57
-0.41
-0.24

Details

Expected EPS
-0.6842
Actual EPS
-0.63
Surprise EPS
0.05
Surprise Percent
+7.92%

Description

4D Molecular Therapeutics (FDMT) has reported earnings of -0.63 per share for Q3 2024.

0 Comments

Share your thoughts